Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Grade II Glioma: early-phase trial registry

2 of 2 indexed Grade II Glioma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Grade II Glioma: 2 US clinical trials tracked, 2 recruiting.

Grade II Glioma is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Oliver Jonas, running 1 of these trials.

Enrollment posture brief

Registry condition grade-ii-glioma

OPEN 2 | RECR 100% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Grade II Glioma (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Grade II Glioma

Grade II Glioma lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Grade II Glioma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Grade II Glioma is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Named interventions

Most-linked intervention names on Grade II Glioma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

DSP-0390 Drug
1 trials
Microdevice Combination
1 trials

US sites by state

Facility locations filed on Grade II Glioma trials. A trial with sites in several states counts in each.

Missouri 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Grade II Glioma page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Grade II Glioma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Oliver Jonas sponsors the most Grade II Glioma trials on record, review their full trial history before evaluating a specific study. See Oliver Jonas's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Grade II Glioma condition card totals 2 registered trials; most-linked intervention DSP-0390; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.